Sitaxentan has been withdrawn from the market because the benefit of treatment does not outweigh the risk of severe hepatotoxicity.
Tadalafil (Adcirca®) (Pulmonary hypertension)
Non Formulary
Telmisartan
Non Formulary
Terazosin
Non Formulary
Tolazoline
Non Formulary
Trandolapril (Gopten®)
Non Formulary
Trandolapril and Verapamil (Tarka®)
Non Formulary
Valsartan
Non Formulary
Several suppliers are experiencing intermittent supply issues with valsartan products.
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Scottish Medicines Consortium
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
Traffic Light Status Information
Status
Description
Red: Medicines which should only be prescribed in secondary care by a specialist.
Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.
Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).
Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.
Brown: Medicines which should only be prescribed in restricted circumstances.
Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.
For continuation in primary care following specialist initiation for hypertension.
For androgenic alopecia. Oral tablets are not licensed for this indication and the solution Regaine® is not available on the NHS (APCO July 2018). 
Unlicensed
Restricted
